mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.02 |